Related Experiment Videos
Anterior ischemic optic neuropathy and aging
1Università di Padova, Clinica Oculistica, Italy.
Summary
Anterior ischemic optic neuropathy (AION) risk factors, including hypertension and diabetes, appear more influential than age. Younger patients with AION generally experience better visual acuity outcomes.
Area of Science:
- Ophthalmology
- Neurology
- Vascular Medicine
Background:
- Optic neuropathy is a significant cause of vision loss.
- Anterior ischemic optic neuropathy (AION) is a common form, with age being a primary risk factor.
- The influence of other risk factors on AION onset and progression requires further investigation.
Purpose of the Study:
- To analyze the age and sex distribution of different optic neuropathies.
- To investigate the impact of various risk factors on the development and outcomes of anterior ischemic optic neuropathy (AION).
- To compare visual acuity and contralateral eye involvement between younger and older AION patients.
Main Methods:
- Retrospective review of 293 patients diagnosed with optic neuropathy at Padua University Eye Clinic.
- Analysis of demographic data, clinical characteristics, and associated conditions in 84 AION patients.
- Assessment of visual acuity, contralateral eye involvement, and the presence of risk factors like hypertension, diabetes, and vascular disease.
Main Results:
- 84 patients (28.7%) had AION, with a mean age of 61.9 years; younger patients (<65) had significantly better visual acuity.
- Contralateral eye involvement occurred in 30.9% of AION patients, with a shorter latency in older individuals (>64).
- Identified risk factors (hypertension, diabetes, vascular disease) were not consistently present, suggesting their influence may be stronger than aging alone.
Conclusions:
- While age is a factor, specific risk factors like hypertension and diabetes may play a more significant role in the onset of AION.
- Younger AION patients demonstrate better visual prognosis compared to older patients.
- Further research into the interplay of vascular risk factors and AION is warranted.